Abstract:OBJECTIVE:To investigate the relationship between neurokinin B (NKB), endothelin-1 (ET-1) and the pathogenesis of hypertensive disorder complicating pregnancy (HDCP). METHODS:22 HDCP, who received antenatal examination in the Department of Obstetrics and Gynecology of Union Hospital of Tongji Medical College in Huazhong University of Science and Technology from March to July in 2005, were selected for the study, including 12 gestational hypertension (gestational hypertension group) and 10 preeclampsia (preeclamptic group); 22 normal pregnant women in the same period were served as control. At different gestational weeks, maternal plasma levels of NKB and ET-1 in three groups were detected by enzyme-linked immunoassay technique, the expression and location of NKB in placenta were examined by immunohistochemical SP, and mRNA expressions of NKB and ET-1 in placenta were measured with RT-PCR method. RESULTS:(1) At 10 - 14, 20 - 24, and 30 - 34 gestational weeks, the plasma levels of NKB and ET-1 in preeclamptic group were (35.6 +/- 5.2), (17.9 +/- 4.3), (39.5 +/- 4.3), (22.7 +/- 3.6), (47.1 +/- 3.3) and (27.5 +/- 3.5) microg/L, respectively; in the control group they were (22.9 +/- 3.3), (10.7 +/- 5.3), (30.2 +/- 3.4), (13.2 +/- 4.1), (34.6 +/- 4.3) and (16.6 +/- 4.8) microg/L, respectively. There was a significant difference between preeclamptic group and control group (P < 0.05), while there was no significant difference between gestational hypertension group and control group (P > 0.05). (2) Immunohistochemical staining for NKB protein was observed in all groups and was located in the villous syncytiotrophoblast and villous vascular endothelial cells as well as cytoplasm of stromal cells, mostly located in villous syncytiotrophoblast. The expressions of NKB in placenta of preeclamptic group (0.244 +/- 0.020) was significantly higher than that in control group (0.160 +/- 0.012), with a significant difference between the two groups (P < 0.05). However, there was no significant difference between gestational hypertension group (0.162 +/- 0.019) and control group (P > 0.05). (3) The transcription levels of the NKB mRNA (0.97 +/- 0.36) and ET-1 mRNA (0.90 +/- 0.36) in preeclamptic placentas were both significantly higher than those in control groups (0.78 +/- 0.54, 0.65 +/- 0.47, respectively), with a significant difference between the two groups (P < 0.05). But there was no significant difference between gestational hypertension group (0.80 +/- 0.40, 0.70 +/- 0.32, respectively) and control group (P > 0.05). (4) There was an evident positive correlation between plasma NKB and ET-1 levels in preeclampsia (r = 0.79, P < 0.05). CONCLUSIONS:The significantly increased maternal plasma levels of NKB and ET-1 of patients with preeclampsia occur at early pregnancy (10 - 14 gestational weeks) before the onset of clinical symptoms. The change of maternal plasma levels of NKB and ET-1 is closely related to pathogenesis of HDCP.

Preliminary Exploration of the Relationship Between NT-ProBNP and Pregnancy Outcomes in Preeclampsia

Study on the Level Changes of N-terminal Pro-B-type Natriuretic Peptide in the Serum of Patients with Pre-eclampsia and Its Clinical Significance

Serum Levels of N-Terminal Pro-Brain Natriuretic Peptide in Gestational Hypertension, Mild Preeclampsia, and Severe Preeclampsia: A Study from a Center in Zhejiang Province, China

Prediction of Adverse Maternal and Perinatal Outcomes in Preeclampsia Based on B-type Natriuretic Peptide: a Retrospective Study.

Increased B-type natriuretic peptide levels in early-onset versus late-onset preeclampsia

Early-pregnancy N-terminal pro-brain natriuretic peptide level is inversely associated with hypertensive disorders of pregnancy diagnosed after 35 weeks of gestation

Intrapartum trends of NT-proBNP and hs-cTnT in patients with severe features of preeclampsia

Changes of serum cardiotropin Ⅰ and cystatin C in preeclampsia and clinical significance thereof

Correlation of 24-h Urinary Protein Excretion, Serum Indicators, and Placental Growth Factor in Patients with Preeclampsia and their Adverse Outcome

Study on relationship between changes of plasma protein in pregnant women with severe preeclampsia and perinatal Outcomes

Pregnancy in a healthy population: dynamics of NTproBNP and hs-cTroponin T

The Correlation Between Maternal Serum Sst2, IL‐33 and NT‐proBNP Concentrations and Occurrence of Pre‐eclampsia in Twin Pregnancies: A Longitudinal Study

[Relationship Between Neurokinin B and Endothelin-1 and Hypertensive Disorders Complicating Pregnancy].

Association Between NT-proBNP and Prolonged Length of Stay in Hospital Among Preterm Infants Born at 28–31 Weeks' Gestation

Predictive Role of Neutrophil-to-lymphocyte Ratio in Preeclampsia: A Meta-Analysis Including 3982 Patients

Study on the Relation Between Concentration of Circulating Non-Host Fetal DNA in Pregnant Women and Pre-Eclampsia

Changes of Serum Neuropeptide Y and Neurotensin in Patients with Pregnancy-Induced Hypertension Syndrome

Study of serum NT-proBNP levels and warning mechanism in common diseases of neonates

Cardiac function in pregnant women with preeclampsia

Study on the Relationship Between Severity of Proteinuria and Perinatal Outcomes in Women with Preeclampsia

A New Predicting Model of Preeclampsia Based on Peripheral Blood Test Value